Stimuli-Responsive Polyacrylamide Nanogels for Iron Chelation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for iron overload, such as deferoxamine and its derivatives, suffer from short half-lives and adverse side effects, and are unable to effectively chelate both iron(II) and iron(III) ions, necessitating co-administration and posing compliance issues.
Innovation Solution
Development of cross-linked polyacrylyl copolymers forming nano-sized structures that can chelate both iron(II) and iron(III) ions, with stimuli-responsive disassembly for rapid renal and biliary clearance, extending pharmacokinetics and improving safety profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If small molecule chelators such as deferoxamine are used, then iron chelation can be achieved, but the half-life is short and side effects occur
Solution Approach 1:
The patent uses composite materials by combining multiple functional subunits within a single polymer chain: iron-chelating subunits (e.g., hydroxamic acid groups), stimuli-responsive cross-linking subunits (e.g., redox-sensitive or hydrolyzable groups), and spacer subunits. This composite structure allows the chelator to achieve both extended half-life and reduced side effects through coordinated functionality, resolving the contradiction between duration of action and harmful effects.
Solution Approach 2:
The patent applies parameter changes by modifying the molecular size and structure parameters of the chelator. By transitioning from small molecule chelators to polymer-based nanogels with controlled molecular weight and size distribution, the patent extends half-life while controlling pharmacokinetics to reduce side effects. The stimuli-responsive cross-linking parameter also enables controlled release and clearance.
2Ease of operation
If single-drug chelators are used, then administration is simplified, but they can only bind one form of iron ion requiring co-administration
Solution Approach 1:
The patent implements universality by designing a single polymer chelator system that can bind multiple forms of iron ions (Fe2+ and Fe3+) through different chelating subunits within the same molecule. The polymer structure includes both hydroxamic acid groups (binding Fe3+) and other iron-chelating moieties (binding Fe2+), allowing one drug to replace multiple iron-binding agents and simplify administration while maintaining versatility.
3Duration of action of moving object
If cross-linked copolymers forming nanostructures are used, then pharmacokinetics are extended, but the structure complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the polymer structure into distinct functional subunits: iron-chelating subunits, stimuli-responsive cross-linking subunits, and spacer subunits. Each segment performs a specific function, and the overall nanogel structure is assembled from these modular components. This segmentation allows complex functionality to be achieved through systematic combination of simpler units, managing structure complexity while extending pharmacokinetics.
Solution Approach 2:
The patent implements dynamics through stimuli-responsive cross-linking subunits that can reversibly change their cross-linking state in response to physiological stimuli (e.g., redox potential, pH). This dynamic behavior allows the nanogel to adapt its structure during circulation, extending pharmacokinetics by preventing rapid clearance while maintaining stability, thereby managing the complexity through functional adaptability rather than static structural complexity.
4Loss of time
If stimuli-responsive disassembly is implemented, then rapid clearance is achieved, but control mechanisms become more complex
Solution Approach 1:
The patent applies self-service by incorporating stimuli-responsive cross-linking subunits that automatically respond to physiological conditions (such as redox potential or pH changes) to trigger disassembly and clearance. The system does not require external control mechanisms or complex regulation; the polymer itself senses and responds to its environment, enabling rapid clearance through inherent material properties rather than complex control systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanostructured copolymers effectively chelate excess iron, reducing tissue damage and organ failure by extending drug action and enhancing safety, while minimizing side effects through controlled release and clearance mechanisms.
Implementation Method 1
comprising cross-linked copolymers that in turn comprises soluble subunits, cross-linking subunits, and iron chelating subunits are capable of chelating iron (II) and/or (III) ions
Implementation Method 2
The stimuli-responsive cross-linking subunits are derived from hydrolyzable diacrylyl monomers or redox-sensitive diacrylyl complexes
Implementation Method 3
The stimuli-responsive cross-linking subunits are derived from hydrolyzable diacrylyl monomers or redox-sensitive diacrylyl complexes
Data Source
AI summary
The present technology provides new compositions comprising at least one cross-linked co-polymer. In some embodiments, the polyacrylamide co-polymer comprises water soluble subunits, cross-linking subunits, and iron chelating subunits. In other embodiments, the co-polymer comprises water soluble units, cross-linking subunits, and substituted subunits, which can be conjugated with iron-chelating agents. When these new particles are exposed to certain environments, such the presence of strong acids or oxidation agents, these particles are capable of breaking up so that the iron chelating agents can chelate iron or other metals from their environments. Methods to prepare these new compositions are also provided. These compositions or compositions comprising nanogels of the present technology may be used to treat metal overload conditions such as iron overload resulting from chronic transfusions.